| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 7 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $22.84M | - | |
| CEO | 188.2K | $1.83M | - | |
| CFO | 101.4K | $987.6K | - | |
| Other | 99.2K | $965.9K | - | |
| Other | 75.3K | $733.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2017 | Hochman David P | Director | Buy | 10,000 | $7.08 | $70,800.00 | +2.2% | |
| Nov 10, 2017 | Moran Sean F.61 | Chief Financial Officer | Buy | 1,500 | $7.04 | $10,560.00 | +0.4% | |
| Nov 10, 2017 | White Barbara | Chief Medical Officer | Buy | 2,836 | $7.00 | $19,852.00 | +1.7% | |
| Nov 10, 2017 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,000 | $7.17 | $7,168.50 | +1.7% | |
| Aug 11, 2017 | White Barbara | Chief Medical Officer | Buy | 2,479 | $6.05 | $14,997.95 | +1.5% | |
| Aug 11, 2017 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,695 | $6.00 | $10,170.00 | +3.0% | |
| Aug 11, 2017 | Moran Sean F.61 | Chief Financial Officer | Buy | 2,500 | $5.91 | $14,775.00 | +0.7% | |
| May 11, 2017 | Catlin Avery W | Director | Buy | 5,000 | $6.15 | $30,740.50 | +11.9% | |
| May 11, 2017 | Hochman David P | Director | Buy | 3,400 | $6.18 | $21,012.00 | +0.7% | |
| May 11, 2017 | Holmer Alan F | Director | Buy | 500 | $6.23 | $3,115.00 | +2.3% |